Microvascular Tissues has a total of 58 patents globally, out of which 33 have been granted. Of these 58 patents, more than 63% patents are active. United States of America is where Microvascular Tissues has filed the maximum number of patents, followed by Europe and Austria. Parallelly, United States of
Kalivir Immunotherapeutics has a total of 71 patents globally, out of which no patent has been granted. Of these 71 patents, more than 92% patents are active. The United States of America is where Kalivir Immunotherapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United
Calidi Biotherapeutics has a total of 62 patents globally, out of which 28 have been granted. Of these 62 patents, more than 91% patents are active. The United States of America is where Calidi Biotherapeutics has filed the maximum number of patents, followed by Japan and Canada. Parallelly, United States
Mirror Biologics has a total of 67 patents globally, out of which 46 have been granted. Of these 67 patents, more than 86% patents are active. The United States of America is where Mirror Biologics has filed the maximum number of patents. Parallelly, United States of America seems to be
Augmenta Bioworks has a total of 23 patents globally, out of which 3 have been granted. Of these 23 patents, more than 56% patents are active. United States of America is where Augmenta Bioworks has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of
Pinetree Therapeutics has a total of 26 patents globally, out of which 8 have been granted. Of these 26 patents, more than 69% patents are active. The USA is where Pinetree Therapeutics has filed the maximum number of patents, followed by Europe, Australia and Canada. Parallelly, Korea (South) seems to
Combined Therapeutics has a total of 48 patents globally, out of which 7 have been granted. Of these 48 patents, more than 83% patents are active. Europe (EPO) is where Combined Therapeutics has filed the maximum number of patents, followed by USA and Japan. Parallelly, USA seems to be the
Phanes Therapeutics has a total of 246 patents globally, out of which 23 have been granted. Of these 246 patents, more than 83% patents are active. China and Europe (EPO) is where Phanes Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the
Khloris Biosciences has a total of 13 patents globally, out of which no patents have been granted. Of these 13 patents, more than 76% patents are active. United States of America is where Khloris Biosciences has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States
Kelonia Therapeutics has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kelonia Therapeutics. Kelonia
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.